Infectious consequences of the AKI-to-CKD transition.

acute kidney injury chronic kidney disease infections outcomes persistent kidney damage

Journal

Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 06 03 2022
entrez: 16 11 2022
pubmed: 17 11 2022
medline: 17 11 2022
Statut: epublish

Résumé

Acute kidney injury (AKI) is associated with short- and long-term complications but the consequences of the AKI-to-CKD transition are still poorly understood. We aimed to evaluate the association between the AKI-to-CKD transition and the long-term risk of infection. This retrospective study included patients admitted in a tertiary hospital with community-acquired AKI in 2013 and 2014 who had their estimated glomerular filtration rate (eGFR) assessed at 3 months (±2 weeks) after serum creatinine peaked in the AKI episode. Key exclusion criteria were baseline CKD or confounding factors (active neoplasia, primary immunodeficiency, human immunodeficiency virus, immunosuppressive drugs). The association between the AKI-to-CKD transition (defined as an eGFR <60 ml/min/1.73 m Among the 1731 patients admitted with AKI, 367 (21%) were included in the present analysis (64% male, 71 ± 15 years). Three months after AKI, 159 (43%) developed AKI-to-CKD transition. Baseline and post-AKI eGFR were independent predictors of AKI-to-CKD transition [hazard ratio (HR) 0.97, The AKI-to-CKD transition independently predicts the long-term risk of infection following an episode of AKI.

Sections du résumé

Background UNASSIGNED
Acute kidney injury (AKI) is associated with short- and long-term complications but the consequences of the AKI-to-CKD transition are still poorly understood. We aimed to evaluate the association between the AKI-to-CKD transition and the long-term risk of infection.
Methods UNASSIGNED
This retrospective study included patients admitted in a tertiary hospital with community-acquired AKI in 2013 and 2014 who had their estimated glomerular filtration rate (eGFR) assessed at 3 months (±2 weeks) after serum creatinine peaked in the AKI episode. Key exclusion criteria were baseline CKD or confounding factors (active neoplasia, primary immunodeficiency, human immunodeficiency virus, immunosuppressive drugs). The association between the AKI-to-CKD transition (defined as an eGFR <60 ml/min/1.73 m
Results UNASSIGNED
Among the 1731 patients admitted with AKI, 367 (21%) were included in the present analysis (64% male, 71 ± 15 years). Three months after AKI, 159 (43%) developed AKI-to-CKD transition. Baseline and post-AKI eGFR were independent predictors of AKI-to-CKD transition [hazard ratio (HR) 0.97,
Conclusions UNASSIGNED
The AKI-to-CKD transition independently predicts the long-term risk of infection following an episode of AKI.

Identifiants

pubmed: 36381366
doi: 10.1093/ckj/sfac178
pii: sfac178
pmc: PMC9664570
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2237-2244

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.

Références

Am J Kidney Dis. 2014 May;63(5):713-35
pubmed: 24647050
Kidney Int. 2017 Aug;92(2):440-452
pubmed: 28416224
Int J Mol Sci. 2022 Feb 01;23(3):
pubmed: 35163625
Am J Kidney Dis. 2021 Nov;78(5):736-749
pubmed: 34518032
Intern Med J. 2022 May;52(5):834-840
pubmed: 33342021
Kidney Int. 2022 Jan;101(1):13-15
pubmed: 34991802
Nat Rev Dis Primers. 2021 Jul 15;7(1):52
pubmed: 34267223
Adv Chronic Kidney Dis. 2019 Jan;26(1):8-15
pubmed: 30876622
An Sist Sanit Navar. 2021 Aug 20;44(2):215-223
pubmed: 34142992
J Am Soc Nephrol. 2022 Feb;33(2):259-278
pubmed: 34907031
Am J Cardiol. 2015 Jul 1;116(1):104-11
pubmed: 25943992
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
Diabetes Care. 2017 Jul;40(7):985
pubmed: 28522558
Lancet. 2013 Jul 13;382(9887):170-9
pubmed: 23727171
Nat Rev Nephrol. 2015 Feb;11(2):88-101
pubmed: 25331787
Contrib Nephrol. 2018;193:45-54
pubmed: 29393158
Kidney Int. 2000 Oct;58(4):1758-64
pubmed: 11012910
J Nephrol. 2019 Dec;32(6):967-975
pubmed: 31617159
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1399-1408
pubmed: 28818849
Nephron. 2020;144(10):498-505
pubmed: 32818930
Nephrol Dial Transplant. 2020 Nov 1;35(11):1894-1900
pubmed: 31219575
Nat Rev Nephrol. 2020 Apr;16(4):193-205
pubmed: 32051567
Am J Kidney Dis. 2013 Jan;61(1):57-66
pubmed: 22889713
Blood Purif. 2016;41(1-3):144-50
pubmed: 26764483

Auteurs

Ana Sánchez Horrillo (AS)

Nephrology Department, Instituto de Investigación Sanitaria La Princesa, Hospital Universitario de La Princesa, Madrid, Spain.

Laura Salanova Villanueva (LS)

Nephrology Department, Instituto de Investigación Sanitaria La Princesa, Hospital Universitario de La Princesa, Madrid, Spain.

Alicia Cabrera Cárdenas (AC)

Nephrology Department, Instituto de Investigación Sanitaria La Princesa, Hospital Universitario de La Princesa, Madrid, Spain.

Patricia Muñoz Ramos (PM)

Nephrology Department, Instituto de Investigación Sanitaria La Princesa, Hospital Universitario de La Princesa, Madrid, Spain.

Alberto Ortiz (A)

School of Medicine, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Universidad Autónoma de Madrid.
Instituto de Investigación Carlos III, Fundación Renal Iñigo Alvarez de Toledo-IRSIN, Madrid, Spain.

Borja Quiroga (B)

Nephrology Department, Instituto de Investigación Sanitaria La Princesa, Hospital Universitario de La Princesa, Madrid, Spain.

Classifications MeSH